| Filed On | Filing |
|---|---|
| 12 Nov 2026 | 10-Q |
| 16 Oct 2026 |
8-K: Entry into a Material Definitive Agreement
THIS SECOND AMENDMENT TO AMENDED AND RESTATED LEASE (this "Second Amendment"), by and between SAN DIEGO INSPIRE 2, LLC, a Delaware limited liability company ("Landlord"), and ORGANOVO, INC., a Delaware corporation ("Tenant"), is made eff... |
| 06 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
to attract and retain the best available personnel for positions of substantial responsibility, |
| 01 Sep 2026 |
Form 4: Lialin Tony Serge, Chief Commercial Officer
Bought 10,000 shares ($2.8K) |
| 21 Aug 2026 | ARS |
| 21 Aug 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
On August 17, 2026, VivoSim Labs, Inc., a Delaware corporation (the “Company”), received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based... |
| 21 Aug 2026 |
Proxy statement: annual meeting on September 30, 2026
CEO pay $866K, down 26% · say-on-pay vote |
| 17 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | PRER14A |
| 12 Aug 2026 | 10-Q |
| 10 Aug 2026 | EFFECT |
| 10 Aug 2026 | PRE 14A |
| 06 Aug 2026 |
8-K: Results of Operations and Financial Condition
San Diego, CA — August 6, 2026 — VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced that on Augu... |
| 31 Jul 2026 | S-1 |
| 30 Jul 2026 |
8-K: Shareholder Director Nominations; Other Events
On July 30, 2026, the Board of Directors of VivoSim Labs, Inc. (the “Company”) set September 30, 2026 (the “Meeting Date”) as the date of the Company’s 2026 Annual Meeting of Stockholders (the “Annual Meeting”) and August 13, 2026 as the... |
| 24 Jul 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events
On July 20, 2026, VivoSim Labs, Inc., a Delaware corporation (the “Company”), received a written notice (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, since t... |
| 17 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
This Securities Purchase Agreement (this “Agreement”) is dated as of July 16, 2026, between VivoSim Labs, Inc., a Delaware corporation (the “Company”), and each of the purchasers identified on the signature pages hereto (including its su... |
| 14 Jul 2026 | 10-K |
| 29 Jun 2026 | NT 10-K |
| 06 Apr 2026 | SCHEDULE 13G |
Loading...